The Medical College of Wisconsin Office of Technology Development is the college’s “technology transfer” office. The Office of Technology Development nurtures intellectual creativity, stimulates research, develops and protects intellectual property, transfers intellectual property to entities best equipped to develop and take the product to market, and strengthens the Medical College of Wisconsin brand with the business community. The Office of Technology Development is housed administratively within the Medical College of Wisconsin Office of Research.
Joseph O. Hill, PhD
As Managing Director of the Office of Technology Development, Dr. Hill supervises staff, budgets and strategic planning, and oversees relationships with industry and internal MCW departments and faculty necessary to achieve our mission. Joe personally manages 70 technologies and has negotiated more than 80 license agreements with existing companies and new ventures, in technologies including medical devices, pharmaceuticals and diagnostics. He received his PhD in Microbiology from West Virginia University and spent 16 years as a translational research scientist studying the immunology of infectious diseases. Joe currently holds an academic appointment as Associate Professor at the Medical College of Wisconsin and Marquette University and teaches courses in intellectual property, medical technology management, and regulatory affairs.
Kalpa Vithalani, PhD
Dr. Vithalani manages 70 technologies and has negotiated a variety of agreements with development partners, including, MOUs, MTAs, CDAs, joint ownership, sponsored research, and option and license agreements. Prior to joining MCW, Kalpa helped Imaging Biometrics, LLC with a successful 510(k) application for their first product. Kalpa was a scientific evaluator for Karolinska Innovations at the Karolinska Institute in Sweden. She received a PhD from the Department of Cell Biology at Duke University and completed her post-doctoral training at the Cleveland Clinic. For the last seven years she has served as a judge for the WI Governor’s Business Plan Contest and is currently a Board member of BIOforward.
James Antczak, PhD
Dr. Antczak manages a portfolio of approximately 70 technologies encompassing 70 pending patent applications or patents, and 30 agreements that are active or in negotiation. Prior to joining MCW, Jim had an extensive career working in the biomedical technology sector, including four university start-up companies where his management responsibilities included research and development, intellectual property protection, licensing, strategic planning, and business development. Jim received a PhD in Microbiology and Immunology from Duke University where he also did the post-doctoral research that led to the first of his three issued patents. Jim is currently a member of the Board of the Wisconsin Technology Council.
William Clarke, MD
Director of Research Commercialization
Dr. Clarke is both a physician and a scientist. He is Board Certified in pediatrics, anesthesiology, pediatric critical care, and pediatric anesthesiology, has helped develop several important drugs used to treat pulmonary hypertension, and has published widely in the field of the basic and clinical science of pulmonary hypertension. Bill has been the Director of Biological Sciences at Glaxo Welcome UK, the Global Head of R&D and EVP at Amersham, Chief Medical Officer for GE Healthcare and an Officer of GE Corporation, and CEO of Cellectar, a biotechnology company in Madison WI. Dr. Clarke now helps faculty who are interested in developing companies based upon IP that has been licensed from MCW.
Edward Diehl, PhD
Dr. Diehl is the technology Marketing Manager for the Office of Technology Development. His major goals are to create awareness of the Office to Medical College of Wisconsin faculty, staff and students, and market technologies to industry and investment clients. He also assists in intellectual property evaluation and development. He joined the Office after eight years with his life science consulting firm The Diehl Group, LLC and three years of service on the Office of Technology Development Technology Innovation Council. Eddie holds a BS in Biology from the Pennsylvania State University and a PhD in Physiology and Biophysics from the University of Iowa.
Ms. Gao has been the Financial Analyst for the Office of Technology Development since December 2014. She received a Bachelor’s Degree in finance from the University of International Business and Economics in Beijing and a Master’s degree in finance from the Rochester Institute of Technology. Yin worked at Macallister Machinery, a Caterpillar dealership, as a staff accountant for three years and subsequently at Juntian Power Design Institute as a financial analyst for another three years.
The Office of Technology Development (OTD) is responsible for managing the discoveries, inventions, and other intellectual property assets of the Medical College of Wisconsin and advancing these assets from Patents to Patients®. In this endeavor, we identify, evaluate and protect intellectual property and then license or otherwise transfer that intellectual property to established companies or spin-off companies to develop commercial products. The Medical College of Wisconsin has robust research and clinical programs that generate a strong pipeline of technologies available for licensing in therapeutics, diagnostics, diagnostic imaging, medical devices, and research tools.& As of July 1, 2015, the Medical College of Wisconsin’s technology portfolio includes: 218 technologies from 334 faculty, fellows, staff and students; 237 pending or issued U.S. and international patents; 36 technologies resulting from collaborations with faculty at other academic institutions or companies; and 62 technologies licensed to companies.
The horizontal organization within the Office of Technology Development allows each Licensing Manager to be responsible for specific technologies in the portfolio over the entire commercialization lifecycle, from intake of invention disclosures, through evaluation of commercial potential, protection of intellectual property (IP), marketing, negotiation of license agreements and maintenance of relationships with industry partners.
In today's knowledge-based economy, academic institutions and companies are increasingly investing in intangible assets, such as intellectual property (IP) vs. tangible assets, such as buildings, personnel and equipment. Intellectual Property has become a major corporate asset. The sales of products and other embodiments of this intellectual property and how they compete in the marketplace is a true measure of innovation. Therefore, companies seek to increase the value of their patent portfolios to position themselves for successful commercial growth by in-licensing intellectual property from universities. The journey from the laboratory to the marketplace relies on a partnership between the Medical College of Wisconsin inventors and the Office of Technology Development. The OTD seeks to stimulate the interest of companies or investors to commit resources to further develop and commercialize Medical College of Wisconsin technology.
The diagram below depicts the non-linear nature of the technology development process, beginning with an invention disclosure, evaluation, patenting, marketing, licensing, commercial development and sales of products by industry partners. Each phase of the process allows multiple points of communication with inventors. Not all disclosures to the Office of Technology Development result in patents but the office always encourages communication from inventors as early as possible.
The Medical College of Wisconsin maintains a Corporate Policy Patent and Copyright (RS.GN.060). This policy is available on MCW’s intranet site. If you have access to InfoScope, search for keywords “research policies” and select the link Research Policies to view details.